nAChR

nAChR

Nicotinic acetylcholine receptors, or nAChRs, are proteins on neurons that signal when a chemical stimulus causes muscles to contract. On the presynaptic and postsynaptic sides of the neuromuscular junction, as well as in the plasma membranes of some neurons, they are cholinergic receptors that create ligand-gated ion channels. The most extensively researched ionotropic receptors are those for nicotinic acetylcholine. The neurotransmitter acetylcholine (ACh) binds to the nAChR, just like it does with the other type of acetylcholine receptor, the muscarinic acetylcholine receptor (mAChR). Nicotinic receptors can be opened by both acetylcholine and nicotine, hence the name "nicotinic," just as muscarinic receptors are so named because they are also activated by muscarine.

nAChR related products

Structure Cat No. Product Name CAS No. Product Description
V4414 Sofiniclin 799279-80-4 Sofiniclin (formerly also known as ABT-894 and A-422894) is a novel and potent agonist ofnicotinic acetylcholine receptor (nAChR) which isused as a potential non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD).
V70701 Spinosad (spinosad) 168316-95-8 Spinosad is a bioneurotoxic insecticide with a broader spectrum of action, a blend of spinosyns A and D, which is a fermentation product of soil actinomycetes.
V70780 SR 16584 1150153-86-8 SR16584 is a selective antagonist of α3β4 nAChR with IC50 of 10.2 μM.
V2189 SUVN-911 2414674-71-6 SUVN-911 is a novel, potent, selective, brain penetrated and orally bioavailable neuronal nicotinic acetylcholine α4β2 receptor antagonist, with a Ki of 1.5 nM.
V70779 TC-1698 700834-58-8 TC-1698 is a selective α7 nicotinic acetylcholine receptor agonist, with EC50s of 0.16 μM and 0.46 μM for monkey α7 nicotinic receptor and human α7 nicotinic receptor, respectively.
V70726 TC-2559 diffuse 2454492-41-0 TC-2559 difumarate is a CNS-selective, orally bioactive partial agonist of the nicotinic acetylcholine receptor (nAChR) α4β2 subtype.
V70713 Tebanicline dihydrochloride (Ebanicline dihydrochloride; ABT-594 dihydrochloride) 209326-19-2 Tebanicline di-HCl (Ebanicline di-HCl) is a modulator of nAChR with potent oral analgesic activity.
V5315 TMPH inhibitor 849461-90-1 nAChR-IN-1 (2,2,6,6-Tetramethylpiperidin-4-yl heptanoate) is a tetramethylpiperidinyl enanthate and a selective nicotinic acetylcholine receptor (nAChR) inhibitor.
V70705 TQS 353483-92-8 TQS is a PAM (positive allosteric modulator) of the α7 nicotinic acetylcholine receptor (nAChR).
V70742 UB-165 200432-86-6 UB-165 is an agonist of nAChR, a full agonist of α3β2 subtype, and a partial agonist of α4β2* subtype.
V70721 UB-165 fumarate 2454492-43-2 UB-165 fumarate is an agonist of nAChR, a full agonist of α3β2 subtype, and a partial agonist of α4β2* subtype.
V5321 Varenicline 249296-44-4 Varenicline (also known as CP 526555),an approved medication used to treat nicotine addiction, is a potent and selective α4β2 nicotinic receptor (nAChR) partial agonist.
V2410 Varenicline dihydrochloride 866823-63-4 Varenicline dihydrochlorideis a nicotinic receptor partial agonist.
V80242 Varenicline-d4 dihydrochloride (varenicline dihydrochloride-d4) Varenicline-d4 (di-HCl) is the deuterated form of Varenicline di-HCl.
V2036 Vecuronium Bromide (ORG NC 45) 50700-72-6 Vecuronium (ORG NC 45) is a non-depolarizing neuromuscular blocking agent widely used as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
V70737 Waglerin-1 145038-84-2 Waglerin-1 is a 22-amino acid (AA) peptide that is a competitive antagonist of muscle nicotine receptors (nAChR).
V70703 α-Bungarotoxin 11032-79-4 α-Bungarotoxin is a competitive antagonist of nicotinic acetylcholine receptors (nAChRs).
V70747 α-Conotoxin AuIA 216299-20-6 α-Conotoxin AuIA is a potent and specific α3β4 n-nAChR inhibitor.
V70735 α-Conotoxin AuIB (α-Conotoxin AuIB) 216299-21-7 α-Conotoxin AuIB is a potent and specific α3β4 nicotinic acetylcholine receptor (nAChR) antagonist.
V73423 α-Conotoxin AuIB TFA (α-Conotoxin AuIB trifluoroacetate) α-Conotoxin AuIB TFA is a potent and specific α3β4 nicotinic acetylcholine receptor (nAChR) antagonist.
Contact Us Back to top